» Articles » PMID: 23945060

Platelet Aggregation Following Trauma: a Prospective Study

Overview
Date 2013 Aug 16
PMID 23945060
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

We aimed to elucidate platelet function in trauma patients, as it is pivotal for hemostasis yet remains scarcely investigated in this population. We conducted a prospective observational study of platelet aggregation capacity in 213 adult trauma patients on admission to an emergency department (ED). Inclusion criteria were trauma team activation and arterial cannula insertion on arrival. Blood samples were analyzed by multiple electrode aggregometry initiated by thrombin receptor agonist peptide 6 (TRAP) or collagen using a Multiplate device. Blood was sampled median 65 min after injury; median injury severity score (ISS) was 17; 14 (7%) patients received 10 or more units of red blood cells in the ED (massive transfusion); 24 (11%) patients died within 28 days of trauma: 17 due to cerebral injuries, four due to exsanguination, and three from other causes. No significant association was found between aggregation response and ISS. Higher TRAP values were associated with death due to cerebral injuries (P < 0.01, when corrected for ISS and platelet counts), whereas lower platelet counts were associated with massive transfusion (P < 0.01, when corrected for ISS and aggregation). An aggregation value of 145 IU by TRAP significantly identified death due to cerebral injury (sensitivity 71% and specificity 76%, P < 0.01) by receiver operating characteristic-curve analysis; the corresponding value of platelet counts for massive transfusion was 189 × 10/l (sensitivity 86%, specificity 75%, P < 0.01). We concluded there was no simple relationship between platelet aggregation and injury severity. Our results indicate that high platelet aggregation values are associated with fatality of cerebral injury.

Citing Articles

Multiplate Platelet Function Testing upon Emergency Room Admission Fails to Provide Useful Information in Major Trauma Patients Not on Platelet Inhibitors.

Pommer P, Oberladstatter D, Schlimp C, Zipperle J, Voelckel W, Lockie C J Clin Med. 2022; 11(9).

PMID: 35566704 PMC: 9100631. DOI: 10.3390/jcm11092578.


The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient.

Fecher A, Stimpson A, Ferrigno L, Pohlman T J Clin Med. 2021; 10(20).

PMID: 34682916 PMC: 8541346. DOI: 10.3390/jcm10204793.


Optimizing transfusion strategies in damage control resuscitation: current insights.

Pohlman T, Fecher A, Arreola-Garcia C J Blood Med. 2018; 9:117-133.

PMID: 30154676 PMC: 6108342. DOI: 10.2147/JBM.S165394.


Evaluation of Potential Clinical Surrogate Markers of a Trauma Induced Alteration of Clotting Factor Activities.

Burggraf M, Payas A, Schoeneberg C, Wegner A, Kauther M, Lendemans S Biomed Res Int. 2016; 2016:5614086.

PMID: 27433474 PMC: 4940535. DOI: 10.1155/2016/5614086.


Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.

Moore H, Moore E, Chapman M, Gonzalez E, Slaughter A, Morton A J Thromb Haemost. 2015; 13(10):1878-87.

PMID: 26256459 PMC: 4838414. DOI: 10.1111/jth.13067.